Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Immuno-oncology Therapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Immuno-oncology Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Immuno-oncology Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Spectrum Pharmaceuticals
Pfizer
Janssen Biotech
Novartis
Merck
Amgen
GlaxoSmithKline
AstraZeneca
Roche
Bristol-Myers Squibb
Sanofi
Eli-Lilly
Takeda
By Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
By End-User:
Hospitals
Ambulatory Surgical Center
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Immuno-oncology Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 China Immuno-oncology Therapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.2 China Immuno-oncology Therapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027
-
1.3.3 China Immuno-oncology Therapy Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
1.3.4 China Immuno-oncology Therapy Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027
-
1.3.5 China Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Immuno-oncology Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center from 2016 to 2027
-
1.4.3 China Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Immuno-oncology Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Immuno-oncology Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.2 Market Size and Growth Rate of Immune Checkpoint Inhibitors
-
3.4.3 Market Size and Growth Rate of Immune System Modulators
-
3.4.4 Market Size and Growth Rate of Cancer Vaccines
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Immuno-oncology Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Immuno-oncology Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Immuno-oncology Therapy in Hospitals
-
4.4.2 Market Size and Growth Rate of Immuno-oncology Therapy in Ambulatory Surgical Center
-
4.4.3 Market Size and Growth Rate of Immuno-oncology Therapy in Others
5 Market Analysis by Regions
-
5.1 China Immuno-oncology Therapy Production Analysis by Regions
-
5.2 China Immuno-oncology Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Immuno-oncology Therapy Landscape Analysis
-
6.1 North China Immuno-oncology Therapy Landscape Analysis by Major Types
-
6.2 North China Immuno-oncology Therapy Landscape Analysis by Major End-Users
7 Central China Immuno-oncology Therapy Landscape Analysis
-
7.1 Central China Immuno-oncology Therapy Landscape Analysis by Major Types
-
7.2 Central China Immuno-oncology Therapy Landscape Analysis by Major End-Users
8 South China Immuno-oncology Therapy Landscape Analysis
-
8.1 South China Immuno-oncology Therapy Landscape Analysis by Major Types
-
8.2 South China Immuno-oncology Therapy Landscape Analysis by Major End-Users
9 East China Immuno-oncology Therapy Landscape Analysis
-
9.1 East China Immuno-oncology Therapy Landscape Analysis by Major Types
-
9.2 East China Immuno-oncology Therapy Landscape Analysis by Major End-Users
10 Northeast China Immuno-oncology Therapy Landscape Analysis
-
10.1 Northeast China Immuno-oncology Therapy Landscape Analysis by Major Types
-
10.2 Northeast China Immuno-oncology Therapy Landscape Analysis by Major End-Users
11 Southwest China Immuno-oncology Therapy Landscape Analysis
-
11.1 Southwest China Immuno-oncology Therapy Landscape Analysis by Major Types
-
11.2 Southwest China Immuno-oncology Therapy Landscape Analysis by Major End-Users
12 Northwest China Immuno-oncology Therapy Landscape Analysis
-
12.1 Northwest China Immuno-oncology Therapy Landscape Analysis by Major Types
-
12.2 Northwest China Immuno-oncology Therapy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Spectrum Pharmaceuticals
-
13.1.1 Spectrum Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Janssen Biotech
-
13.3.1 Janssen Biotech Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Novartis
-
13.4.1 Novartis Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Merck
-
13.5.1 Merck Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Amgen
-
13.6.1 Amgen Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 GlaxoSmithKline
-
13.7.1 GlaxoSmithKline Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 AstraZeneca
-
13.8.1 AstraZeneca Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Roche
-
13.9.1 Roche Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Bristol-Myers Squibb
-
13.10.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Sanofi
-
13.11.1 Sanofi Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Eli-Lilly
-
13.12.1 Eli-Lilly Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Takeda
-
13.13.1 Takeda Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center from 2016 to 2027
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Immuno-oncology Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Immuno-oncology Therapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Immuno-oncology Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of Immuno-oncology Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Immune Checkpoint Inhibitors
-
Figure Market Size and Growth Rate of Immune System Modulators
-
Figure Market Size and Growth Rate of Cancer Vaccines
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Immuno-oncology Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Immuno-oncology Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Ambulatory Surgical Center
-
Figure Market Size and Growth Rate of Others
-
Table China Immuno-oncology Therapy Production by Regions
-
Table China Immuno-oncology Therapy Production Share by Regions
-
Figure China Immuno-oncology Therapy Production Share by Regions in 2016
-
Figure China Immuno-oncology Therapy Production Share by Regions in 2021
-
Figure China Immuno-oncology Therapy Production Share by Regions in 2027
-
Table China Immuno-oncology Therapy Consumption by Regions
-
Table China Immuno-oncology Therapy Consumption Share by Regions
-
Figure China Immuno-oncology Therapy Consumption Share by Regions in 2016
-
Figure China Immuno-oncology Therapy Consumption Share by Regions in 2021
-
Figure China Immuno-oncology Therapy Consumption Share by Regions in 2027
-
Table North China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table North China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure North China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure North China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure North China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table North China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table North China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure North China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure North China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Central China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table Central China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure Central China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure Central China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure Central China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table Central China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table Central China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure Central China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure Central China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table South China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table South China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure South China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure South China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure South China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table South China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table South China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure South China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure South China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table East China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table East China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure East China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure East China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure East China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table East China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table East China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure East China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure East China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Northeast China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table Northeast China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure Northeast China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure Northeast China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table Northeast China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure Northeast China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure Northeast China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Southwest China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table Southwest China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure Southwest China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure Southwest China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table Southwest China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure Southwest China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure Southwest China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Northwest China Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table Northwest China Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure Northwest China Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure Northwest China Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table Northwest China Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure Northwest China Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure Northwest China Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Spectrum Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals
-
Table Product and Service Introduction of Spectrum Pharmaceuticals
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Janssen Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Biotech
-
Figure Sales and Growth Rate Analysis of Janssen Biotech
-
Figure Revenue and Market Share Analysis of Janssen Biotech
-
Table Product and Service Introduction of Janssen Biotech
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Eli-Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli-Lilly
-
Figure Sales and Growth Rate Analysis of Eli-Lilly
-
Figure Revenue and Market Share Analysis of Eli-Lilly
-
Table Product and Service Introduction of Eli-Lilly
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
